書誌事項
- 公開日
- 2006-02-28
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1111/j.1423-0410.2006.00740.x
- 公開者
- Wiley
この論文をさがす
説明
<jats:p>Infectious agents of disease continue to plague transfusion medicine as an increasing number of pathogens are described that pose a potential blood safety risk. While the recent focus has been on newly emerged agents, several well‐established pathogens provide timely reminders that other agents continue to pose threats, but invariably ‘fly under the radar’, thereby failing to elicit adequate measures to prevent their transmission by blood transfusion. Perhaps foremost among this group of agents are the <jats:italic>Babesia</jats:italic> spp., which have been known to cause human disease, in the USA, for close to 40 years. <jats:italic>B. microti</jats:italic>, <jats:italic>B. divergens</jats:italic> and several <jats:italic>Babesia</jats:italic>‐like agents are responsible for a growing number of human babesiosis infections. Concomitantly, in the USA, there has been a sharp rise in the number of transfusion‐transmitted infections of <jats:italic>Babesia</jats:italic> spp., attributable almost exclusively to <jats:italic>B. microti</jats:italic>. Despite the obvious public health issues posed by <jats:italic>Babesia</jats:italic> spp., options for preventing their transmission by blood transfusion remain limited. However, recognition that the <jats:italic>Babesia</jats:italic> spp. are indeed an ongoing and expanding blood safety threat will probably prove instrumental in the development of viable interventions to limit transmission of these agents.</jats:p>
収録刊行物
-
- Vox Sanguinis
-
Vox Sanguinis 90 (3), 157-165, 2006-02-28
Wiley